Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maren Runchang Pill for irritable bowel syndrome with constipation
ChiCTR2500095358Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine
- Start
- Jan 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Ma Ren Run Chang Wan in irritable bowel syndrome (IBS), sponsored by Beijing University of Chinese Medicine. Primary endpoint: Response rate of complete spontaneous bowel movements within 4 weeks of treatment. Started Jan 2025; status: completed.
02
Drugs
Ma Ren Run Chang Wan
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ChiCTR2500095358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500095358.